{"public_id":"co_0d69a0c57401a182b8a67e907ef415ff","status":"active","merged_into_public_id":null,"resolved_public_id":"co_0d69a0c57401a182b8a67e907ef415ff","name":"interval debulking surgery","description":"Cytoreductive surgery performed after neoadjuvant chemotherapy in advanced ovarian cancer.","aliases":["IDS"],"types":["surgical procedure"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":251109470,"title":"Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study","citation_count":5,"url":"https://sah.borca.ai/papers/251109470"}],"claims":[{"public_id":"cl_275d8d395132f8153a355880f1e3e92e","text":"Postoperative grade 3 or 4 complications are similar between the two treatment groups.","corpus_id":251109470,"url":"https://sah.borca.ai/claims/cl_275d8d395132f8153a355880f1e3e92e"},{"public_id":"cl_db48d59aef7f464f0dbc773481f2a28d","text":"Adding hyperthermic intraperitoneal chemotherapy to interval debulking surgery is associated with longer progression-free survival than interval debulking surgery without hyperthermic intraperitoneal chemotherapy.","corpus_id":251109470,"url":"https://sah.borca.ai/claims/cl_db48d59aef7f464f0dbc773481f2a28d"},{"public_id":"cl_dff0a59bfb102a730cde14e37c783499","text":"Overall survival does not differ between patients treated with interval debulking surgery with hyperthermic intraperitoneal chemotherapy and those treated without it.","corpus_id":251109470,"url":"https://sah.borca.ai/claims/cl_dff0a59bfb102a730cde14e37c783499"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_0d69a0c57401a182b8a67e907ef415ff","url":"https://sah.borca.ai/concepts/co_0d69a0c57401a182b8a67e907ef415ff"}